Sign in
4

Changes in Ownership

GRI Bio, Inc. Filed Acc 0001104659-21-068828

Options or other derivatives

  • Chief Executive Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baker David Charles · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-14 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/tm2116776-2_4.xml…